Ebola virus continues to rise

On May 28, Congolese officials recorded an additional Ebola death toll, raising the number of deaths in the new outbreak to 12.

Picture 1 of Ebola virus continues to rise
Medical staff prepares to inject Ebola vaccine for patients in Congo.(Photo: AP).

According to TIME, the latest fatal case occurred at Iboko, the rural northwest of Equateur province. Thus, in the May outbreak, the number of viral infections in the Congo reached 35. This is the ninth time Ebola has attacked this Central African nation since 1976.

Worried about virus spread, a series of Iboko schools were temporarily closed. Sharing on local radio stations, many people said they did not dare to go out to contact neighbors.

In order to control Ebola, Congolese officials launched a vaccination campaign for people at high risk of infection, such as doctors and patients' families. As of May 28, more than 360 people have been vaccinated with the Ebola vaccine.

There is currently no treatment for Ebola. The virus spreads from wild animals to people or from people through people through contact with the patient's body fluids (including dead people). Ebola symptoms include high fever, vomiting, diarrhea, muscle pain, internal and external bleeding. The death rate can be up to 90% depending on the situation.

raging Central African countries from March 2014 to the end of 2015. The rapid disease outbreak became the most dangerous in the history of this virus since it was first discovered in 1976. After more than 20 months, the Patriarch The World Health Organization recorded 28,637 cases from 6 countries: Liberia, Guinea, Sierra Leone, Nigeria, the US and Mali, of which 11,315 died. The number of deaths due to this pandemic is five times higher than other outbreaks combined.

In early 2016, the World Health Organization announced the Ebola pandemic ended. Since then, occasionally Ebola has reappeared small epidemics in West African countries. Developed countries have begun to study the production of Ebola vaccines and have had initial success, but there are currently no drugs to treat the disease.